Stocks and Investing
Stocks and Investing
Thu, October 11, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BHVN) at Buy with Increased Target to $47 on, Oct 11th, 2018
Matthew Harrison of Morgan Stanley, Maintained "Biohaven Ltd." (BHVN) at Buy with Increased Target from $45 to $47 on, Oct 11th, 2018.
Matthew has made no other calls on BHVN in the last 4 months.
There are 2 other peers that have a rating on BHVN. Out of the 2 peers that are also analyzing BHVN, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Charles Duncan of "Cantor Fitzgerald" Initiated at Buy and Held Target at $55 on, Thursday, August 23rd, 2018
- Brandon Folkes of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $50 on, Thursday, July 12th, 2018